Skip to content
Clinical Trials – home
Research site

Klin Med s.r.o.

Czechia Jugoslavska 567/16, Vinohrady, 120 00 Prague, Czechia

  • 2 trials recruiting
  • Hepatitis D · Autoimmune hepatitis · Metabolic dysfunction-associated steatohepatitis
  • Adult patients

About Specializations

Klin Med s.r.o. in Prague, Czechia specialises in clinical trials of conditions such as Hepatitis D, Autoimmune hepatitis, Metabolic dysfunction-associated steatohepatitis, Non-alcoholic steatohepatitis, and other specialisations. This site conducts important research.

Main research areas of the site

Hepatology

The medical center is at the forefront of hepatology, focusing on innovative treatments for liver diseases. The ongoing research in this field is particularly centered on Non-alcoholic Steatohepatitis (NASH), a progressive liver disease that can lead to cirrhosis and liver failure.

  • Non-alcoholic Steatohepatitis (NASH) Resolution
  • Fibrosis Management
  • Safety and Tolerability of New Therapies

Through rigorous clinical trials, the center is evaluating the efficacy of novel compounds like efinopegdutide in achieving NASH resolution without worsening fibrosis, while also ensuring patient safety and treatment tolerability.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Jugoslavska 567/16, Vinohrady120 00 PragueCzechia
Recruiting now
2 trials
Conditions studied
4

More sites in PragueCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bjt-778
  • Sponsor:Mirum Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bjt-778
  • Sponsor:Mirum Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ianalumab
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Efinopegdutide
  • Sponsor:Merck Sharp & Dohme LLC
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.